Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CytomX Therapeutics, Inc. - Common Stock
(NQ:
CTMX
)
5.450
-1.300 (-19.26%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 17, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CytomX Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
CytomX Stock Hits 2-Month High After Upbeat Q1 Earnings, Promising Early Data For Cancer Drug
↗
May 12, 2025
The company shared Phase 1 trial results for CX-2051, an antibody-drug conjugate for advanced colorectal cancer, with 28% of patients achieving confirmed partial responses.
Via
Stocktwits
Top movers analysis one hour before the close of the markets on 2025-05-12: top gainers and losers in today's session.
↗
May 12, 2025
Curious to know what's happening on the US markets one hour before the close of the markets on Monday? Join us as we explore the top gainers and losers in today's session.
Via
Chartmill
Monday's session: most active stocks
↗
May 12, 2025
These stocks are making the most noise in today's session. Stay tuned for the latest updates!
Via
Chartmill
Stocks Under $1 to Watch: TAOP, WLGS, HIT, CTMX, JYD – Major Updates, Earnings & Offerings, More Inside….
May 12, 2025
Via
AB Newswire
Topics
Economy
Earnings Scheduled For May 12, 2025
↗
May 12, 2025
Via
Benzinga
Exploring CytomX Therapeutics's Earnings Expectations
↗
May 09, 2025
Via
Benzinga
(CTMX) - Analyzing CytomX Therapeutics's Short Interest
↗
June 05, 2024
Via
Benzinga
Which stocks are moving on Monday?
↗
May 12, 2025
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
↗
May 12, 2025
Via
Benzinga
These stocks are gapping in today's session
↗
May 12, 2025
In today's session, there are notable price gaps in the US markets on Monday. Take a closer look at the stocks that are gap up and gap down.
Via
Chartmill
Nano-Cap CytomX Therapeutics Stock Surges On Heels Of Cancer Data Report
↗
May 12, 2025
CytomX reported early Phase 1 data for CX-2051 in advanced colorectal cancer, with a 94% disease control rate.
Via
Benzinga
Top movers in Monday's pre-market session
↗
May 12, 2025
Wondering what's happening in Monday's pre-market session? Find an overview in this article.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
May 12, 2025
Via
Benzinga
Wondering what's happening in today's pre-market session?
↗
May 09, 2025
Let's have a look at what is happening on the US markets before the opening bell on Friday. Below you can find the top gainers and losers in today's pre-market session.
Via
Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
May 09, 2025
Via
Benzinga
These stocks are gapping in today's session
↗
May 05, 2025
The market is buzzing with gapping stocks on Monday. Let's uncover which stocks are experiencing notable gaps during today's session.
Via
Chartmill
Curious about the stocks that are showing activity after the closing bell on Monday?
↗
April 28, 2025
The US market regular session of Monday is over, let's have a look at the top gainers and losers in the after hours session today.
Via
Chartmill
12 Health Care Stocks Moving In Monday's After-Market Session
↗
April 28, 2025
Via
Benzinga
Which stocks have an unusual volume on Monday?
↗
March 10, 2025
Which stocks have an unusual volume on Monday?
Via
Chartmill
Friday's pre-market session: top gainers and losers
↗
March 07, 2025
As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via
Chartmill
Why Gap Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
↗
March 07, 2025
Via
Benzinga
Earnings Scheduled For March 6, 2025
↗
March 06, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
November 08, 2024
Via
Benzinga
CTMX Stock Earnings: CytomX Therapeutics Beats EPS, Beats Revenue for Q2 2024
↗
August 08, 2024
CTMX stock results show that CytomX Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Buy Alert: 3 Penny Stocks That Will Explode in 2024
↗
June 05, 2024
Investors should consider these three penny stocks to buy before their success makes them more expensive to gain from.
Via
InvestorPlace
No Memes, Ma’am! Try a Sensible Biotech Bet With CytomX Therapeutics Stock.
↗
May 29, 2024
It's time to take CytomX Therapeutics stock seriously as CytomX Therapeutics forges a crucial partnership with a pharmaceutical powerhouse.
Via
InvestorPlace
Analysts' Varied Perspectives On CytomX's CX-904 Cancer Study: Safety Profile But Caution in Pancreatic Cancer
↗
May 09, 2024
Initial data from CytomX Therapeutics' CX-904 Phase 1a study shows safety and anti-cancer activity in heavily pretreated patients with advanced metastatic solid tumors. Reductions observed, especially...
Via
Benzinga
Gold Moves Higher; Roblox Issues Weak Outlook
↗
May 09, 2024
Via
Benzinga
Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
May 09, 2024
Via
Benzinga
SOUN Stock Alert: SoundHound AI Announces New Partnership With Perplexity
↗
May 09, 2024
SoundHound AI stock is slipping on Thursday as SOUN investors appear unimpressed by a new LLM collaboration with Perplexity.
Via
InvestorPlace
Topics
Artificial Intelligence
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
